Hamacher to host CE presentations at AmerisourceBergen’s National Healthcare Conference & Exposition
WAUKESHA, Wis. — Hamacher Resource Group will be hosting a series of continuing education presentations at AmerisourceBergen’s National Healthcare Conference & Exposition in Las Vegas from July 22 to 23.
Dave Wendland and Tom Boyer, both part of the owners group at HRG, will present four different educational sessions.
Of the four sessions presented by HRG, Wendland will present one for the management track (“Retail Realities” on July 22, from 8 a.m. to 9:30 a.m.) and one for the drug information track (“Linking OTC Products with the Rx Department” on July 23, from 8 a.m. to 9:30 a.m). Boyer will present one for the merchandising track (“Merchandising Basics,” on July 23, from 8 a.m. to 9:30 a.m.) and one for the marketing track (“Enhancing the Bottom Line: Five Profit Variables” on July 23, from 1 p.m. to 2:30 p.m.). Each session is worth 1.5 CE credits.
Wendland, a thought leader and a 20-year veteran in the retail consumer healthcare industry, also is a regular contributor to HealthCare Distributor, writes for RetailWire’s BrainTrust blog and has spoken at such events as the Efficient Collaborative Retail Marketing Disease State Management conference and Drug Store News’ Diabetes Roundtable. He also has moderated several panels and hosted multiple industry webinars.
Boyer, a national account manager at HRG, has extensive industry knowledge and has been with HRG since 1994. Most recently he has led a pharmacy curriculum project for colleges of pharmacy and helped shape HRG’s Retail Building Blocks: Home Health Care series. A frequent speaker at pharmacy schools and other industry events, Boyer also works directly with community-based pharmacies providing store assessments and performance report cards.
Hi-Tech Pharmacal’s generic Levaquin enters market
AMITYVILLE, N.Y. — Hi-Tech Pharmacal has introduced levofloxacin oral solution in the 25-mg/mL strength, the drug maker said Tuesday.
The drug will be available in 480-mL, 200-mL and 100-mL sizes in order to allow pharmacists to tailor inventory to store volume. Hi-Tech was granted tentative approval in April.
The drug is a generic version of Johnson & Johnson’s pneumonia treament Levaquin.
Valeant inks distribution agreement for Zuacta in Canada
MISSISSAUGA, Ontario — Canadian drug maker Valeant Pharmaceuticals International has signed an agreement with Sanofi’s subsidiary in Canada to distribute a topical medication for osteoarthritis in the country.
Valeant said Tuesday that it had reached an agreement with Sanofi-Aventis Canada for Canadian marketing and distribution rights to Zuacta (zucapsaicin), designed for treating osteoarthritis of the knee.
“Zuacta will be another strong addition to our product portfolio in Canada, where Valeant has an expertise and focus in the area of pain management,” Valeant chairman and CEO J. Michael Pearson said. “Zuacta has already been approved by Health Canada, and we expect to launch this compound in the third quarter of 2011.”